Frank X. Leonard is President at NovoCure Ltd (NVCR). They have made 30 open-market trades across 1 company since 2021, most recently 2026-06-30.
CIK 0001822879
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 30 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVCR | 461,425 | $6.7M |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVCR | SELL | 2026-06-04 | 2026-06-05 | $17.93 | $615K | +1.7% | -1.5% | +0.6% |
| NVCR | SELL | 2026-03-04 | 2026-03-05 | $13.31 | $75K | -9.5% | -22.8% | +18.5% |
| NVCR | SELL | 2026-02-27 | 2026-03-03 | $13.59 | $231K | -8.5% | -20.0% | +25.6% |
| NVCR | SELL · 10b5-1 | 2025-06-02 | 2025-06-04 | $17.45 | $1.0M | +7.9% | +1.7% | -26.6% |
| NVCR | SELL | 2025-03-03 | 2025-03-04 | $18.54 | $47K | +7.9% | -6.0% | -5.7% |
| NVCR | SELL | 2025-02-27 | 2025-03-03 | $19.64 | $552K | +13.1% | +1.1% | -3.9% |
| NVCR | SELL | 2024-11-01 | 2024-11-04 | $15.94 | $10K | +2.3% | +80.5% | +46.7% |
| NVCR | SELL | 2024-03-01 | 2024-03-05 | $16.02 | $40K | -14.6% | -12.7% | +45.9% |
| NVCR | SELL | 2024-02-28 | 2024-02-29 | $16.14 | $34K | -0.4% | +0.9% | +43.4% |
| NVCR | SELL | 2023-03-03 | 2023-03-07 | $75.71 | $1.6M | -23.5% | -15.5% | +10.6% |
| NVCR | SELL | 2023-03-02 | 2023-03-03 | $75.35 | $596K | -15.9% | -22.8% | -4.0% |
| NVCR | SELL | 2023-03-02 | 2023-03-06 | $76.95 | $447K | -14.8% | -17.9% | +9.1% |
| NVCR | SELL | 2023-03-01 | 2023-03-02 | $76.36 | $257K | -11.2% | -20.6% | -5.2% |
| NVCR | SELL | 2023-01-05 | 2023-01-09 | $112.66 | $4.8M | -3.3% | -1.5% | -30.3% |
| NVCR | SELL | 2022-10-13 | 2022-10-17 | $76.01 | $1.0M | -10.7% | +7.9% | +21.4% |
| NVCR | SELL | 2022-10-06 | 2022-10-07 | $84.37 | $1.1M | -12.2% | -10.7% | +46.8% |
| NVCR | SELL | 2022-09-29 | 2022-09-30 | $77.35 | $1.0M | +3.7% | -7.3% | -6.3% |
| NVCR | SELL | 2022-09-22 | 2022-09-26 | $77.00 | $520K | +13.9% | -9.7% | -8.1% |
| NVCR | SELL | 2022-09-15 | 2022-09-19 | $88.09 | $1.7M | -5.8% | -13.1% | -9.8% |
| NVCR | SELL | 2022-09-09 | 2022-09-12 | $88.00 | $164K | -13.4% | -8.7% | -10.4% |
| NVCR | SELL | 2022-09-08 | 2022-09-13 | $81.48 | $1.1M | -16.2% | -11.1% | -11.2% |
| NVCR | SELL | 2022-09-06 | 2022-09-07 | $78.57 | $217K | +1.0% | -0.2% | -9.8% |
| NVCR | SELL | 2022-09-01 | 2022-09-06 | $77.53 | $1.8M | +10.6% | +8.5% | -0.8% |
| NVCR | SELL | 2022-08-02 | 2022-08-03 | $69.66 | $29K | +16.0% | +8.2% | +0.7% |
| NVCR | SELL | 2022-03-08 | 2022-03-09 | $70.10 | $104K | +8.0% | +18.3% | +7.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.